Senior paralegal · Healthcare compliance expert witness · Retained through counsel

Andrew
Hillman

A Dallas senior paralegal and healthcare compliance and regulatory expert witness, retained through counsel in federal matters nationwide, drawing on three decades of prior healthcare operations, now concluded.

Andrew Hillman
1995
Family office founded
89+
Ventures
85+
Strategic exits
3
Decades, FDA-regulated
Coverage of his companies has appeared in
Each outlet links to the original coverage in the press & media kit.
Andrew Hillman
Principal

Andrew Hillman.

Andrew Jonathan Hillman is a Dallas senior paralegal and healthcare compliance and regulatory expert witness, retained through counsel in federal matters nationwide, drawing on three decades of prior experience building and operating FDA-regulated healthcare companies, now concluded. He maintains a private family office, Hillman Ventures, whose activities are kept private. Born and raised in Oak Cliff and South Dallas, he grew up working in the family businesses from the age of six and finished high school at Highland Park, class of 1995, a self-made arc that still shapes how he builds. He has since completed Harvard online courses in Jewish studies.

Andrew Hillman, Dallas, Texas
Core focus areas

Where the work concentrates.

Four areas define the practice today, each grounded in three decades of healthcare operations and compliance.

Regulatory governance and compliance

Policy lifecycle management, SOP drafting, board reporting, and internal controls, conducted under retaining counsel.

How it works →

Internal audit and investigations

Triage, document-retention playbooks, and internal compliance review across Stark, Anti-Kickback, and HIPAA matters, under counsel.

How it works →

Litigation and defense support

Evidentiary review, subpoena compliance, and expert-report support for white-collar and regulatory defense, under retaining counsel.

Advisory services →

Expert witness engagements

Operator testimony on healthcare operations and compliance, retained through counsel in federal matters nationwide.

Advisory services →
Featured insights

Essays on building in biotech and healthcare.

Selected writing on commercialization, the FDA pathway, manufacturing, and the science behind modern medicine.

Why most biotech startups fail

The real reasons behind commercialization breakdown, from clinical odds to capital and manufacturing.

Read the essay →

FDA approval process explained

A founder's guide from the IND to approval, including 351(a) biologics and expedited pathways.

Read the guide →

Why manufacturing is the real moat

Why process and manufacturing, not the molecule alone, decide which healthcare companies win.

Read the essay →

What is modern cancer research?

A plain-language guide to current approaches in oncology, for education only.

Read the guide →

View all featured insights →

The work

Three decades in FDA-regulated healthcare.

Across three decades, now concluded, Andrew Jonathan Hillman co-founded, operated, and exited companies across surgical hospitals, ambulatory surgical centers, clinical laboratories, pharmacy, and medical devices. That operating experience now informs his healthcare compliance and expert-witness work. Hillman Ventures, his family office founded in 1995, remains private.

The complete, source-cited account, public filings, recognitions, and federal records, is maintained independently at andrewhillmanrecord.com. Investment activity is detailed at Hillman Ventures, and community work at andrewhillman.org.

Selected ventures

Co-founded operating companies and strategic exits.

A selection from 89+ ventures across three decades, with locations. The full portfolio and exits are documented on the record.

Surgical hospitals & ambulatory centers

Victory Medical Center (network) SEC Form DTX, Plano · Houston · San Antonio · McKinney
Champion Medical CenterBaton Rouge, LA
Texas Clinic Surgery CenterPlano, TX
Prestonwood Surgery CenterPlano, TX
Surgery Specialty Hospitals of AmericaHouston, TX
Alpha Treatment CentersIrving, TX

Laboratories & pharmacy

Medicus LaboratoriesDallas, TX
American Laboratories GroupDallas, TX
Infinity Toxicology SEC Form DDallas, TX
Cornell PharmacyDallas, TX

Devices, biologics & holdings

Bone Solutions, Inc., FDA 510(k), exited 2021Southlake, TX
Surgical management companyDallas, TX
L2 SurgicalDallas, TX
Texas IO MonitoringDallas, TX
Business Partners in Health CareDallas, TX
Next Health USADallas, TX

View the full documented portfolio and exits →

Key facts

The essentials, on the record.

Name
Andrew Jonathan Hillman (Andrew J. Hillman). Dallas, Texas.
Role
Principal of Hillman Ventures, a private family office founded in 1995.
Focus
Frontier biotech for inflammation, damaged tissue, and tumor-based cancers.
Operating record
Three decades in FDA-regulated healthcare across surgical hospitals, ambulatory surgical centers, clinical laboratories, pharmacy, and medical devices. 89+ ventures, 85+ strategic exits.
Healthcare ownership
Past owner and operator of a Class A retail pharmacy, a Class G administrative pharmacy, and a wholesale pharmacy distributor, and of ambulatory surgical centers, acute care hospitals, and a rehabilitation hospital. Now advancing breakthroughs in biotech drugs, technologies, and devices, harnessing these innovations to change medicine for the better.
Also
Author of The Hillman Letter on regulatory strategy and the Andrew Hillman Dallas blog, and strategic advisory at andrewhillmanadvisor.com.
Public record
Registered Texas lobbyist in 2001 (Texas Ethics Commission lobby registry), and publisher on Issuu.
Verification
Independent, source-cited record at andrewhillmanrecord.com, profile at Wikidata, LinkedIn, and ORCID.
Focus areas

Where the work goes now.

Hillman Ventures

Andrew Hillman's private family office. Its activities and holdings are kept private by design.

Hillman Ventures →

Community & giving

The Andrew Hillman Family Room at the Lamplighter School, the Scholarship for Entrepreneurs, and the Grant for Biotech.

Service record →

Writing

The Hillman Letter, notes on healthcare regulatory strategy, compliance, and enforcement.

The Hillman Letter →
Transactions & M&A track record

Healthcare deals, taken private and public.

Andrew Hillman has helped take healthcare companies private and public, and has bought and sold healthcare businesses across multiple sectors. His portfolio includes Bone Solutions, Inc. (Southlake, Texas), an orthobiologics company with eight FDA 510(k) clearances.

Taken private

The Apothecary Shop pharmacies (formerly Over the Counter, OTC) and Digimed.

Public markets

Dynacq Healthcare (NASDAQ: DYII). The former Victory Hospitals, acquired by Nobilis Health Corp. (HLTH). Vista Hospital (Dallas, Texas, Baton Rouge, Louisiana, and Houston, Texas), a past hospital ownership. Andrew Hillman states Vista Hospital ranked number 2 on a 2002 Forbes list. That distinction reflects his account and is not independently verified here.

Bought & sold

Medical groups, anesthesia groups, chiropractic groups, MRI and imaging centers, clinical laboratories, and pharmacies.

Verified identity and independent record

A record you can check.

Andrew Hillman's background is documented in an independent, source-cited record and in established identity registries.

The Andrew Hillman RecordWikidataLinkedInORCIDBlueskyIMDbCrunchbase (pending)
Authored work

Published research.

Andrew Hillman is the author of a white paper on Wharton's Jelly-derived mesenchymal stem cell exosomes, examining the underlying science, the FDA Section 351(a) biologic classification, cGMP manufacturing, and the regulatory pathway for cell-free regenerative medicine.

Exosome and mesenchymal stem cell derived extracellular vesicle products are not approved by the FDA for any indication. The work referenced here describes published scientific literature. It does not describe an available treatment.

Last Part Standing book cover
Authored work · Book

Last Part Standing

Andrew Jonathan Hillman, with Beverly Levine.

A book by Andrew Jonathan Hillman, available in paperback and Kindle editions.

Paperback ISBN 979-8184773162 · 58 pages · 2026

Exosome and mesenchymal stem cell derived extracellular vesicle products are not approved by the FDA for any indication. The work referenced here describes published scientific literature. It does not describe an available treatment.

About DOIs and permanent links

A DOI, or Digital Object Identifier, is a permanent identifier for a document. It always resolves at https://doi.org/ followed by the DOI, even when the file location changes. Each paper below that carries a DOI can be cited by that DOI as its permanent link. OpenAIRE holds an independent backup record.

  • Wharton's Jelly MSC-Derived Exosomes in Spinal Disc Repair. Permanent DOI 10.5281/zenodo.20978822. OpenAIRE backup record.
  • MSC-Derived Extracellular Vesicles for Tissue Repair, a Narrative Review. Permanent DOI 10.5281/zenodo.21047848. OpenAIRE backup record.
  • Wharton's Jelly MSC-Derived Exosomes, regulatory monograph on the FDA 351(a) CBER pathway. DOI pending. A permanent DOI will be added here once the Zenodo record is issued.

Exosome and mesenchymal stem cell derived extracellular vesicle products are not approved by the FDA for any indication. The work referenced here describes published scientific literature. It does not describe an available treatment.

https://orcid.org/0009-0001-5396-321XAcademia.edu profileAndrew Hillman ORCID iD QR code
Beyond the work

Giving back.

Andrew Hillman enjoys mentoring young people in business, an interest that pairs naturally with the Andrew Hillman Scholarship for Entrepreneurs. He is also a donor to and supporter of community and charitable organizations, including the Altus Foundation in Houston, the charitable foundation affiliated with ZT Corporate. His giving also includes family memorial gifts: a room named at Temple Emanu-El in loving memory of his grandmother, Fannie Bella Levine, and a nursing station at Methodist Dallas Medical Center in memory of his grandfather, Henry Bergman Levine. He also supports the Heroes for Israel Project, a 501(c)(3) nonprofit supporting Israel's border communities and volunteer first responders, with a $100,000 gift in 2025.

Giving timeline

A record, year by year.

Dated, verifiable milestones in community giving. Each entry is documented on this site or a third-party record.

  1. 2018

    Hillman Family Room established at The Lamplighter School

    A $300,000 gift established the Hillman Family Room at The Lamplighter School in Dallas. The Hillman Family Room is a named technology and robotics space for students.

  2. 2020 to 2026

    Annual gifts to Parish Episcopal School

    Annual donations to Parish Episcopal School in Dallas, Texas, every year from 2020 through 2026.

Organizations supported

Education giving.

Key facts

On the record.

Total giving, The Lamplighter School
More than $500,000 in cumulative gifts to The Lamplighter School in Dallas, Texas, including the $300,000 Hillman Family Room.
Hillman Family Room
A $300,000 gift in 2018 established the Hillman Family Room at The Lamplighter School in Dallas. The Hillman Family Room is a named technology and robotics space for students.
Parish Episcopal School
Annual donations to Parish Episcopal School in Dallas, Texas, every year from 2020 through 2026.
Location
The Lamplighter School, Dallas, Texas.
Frequently asked questions

Andrew Hillman, answered.

Who is Andrew Jonathan Hillman?
Andrew Jonathan Hillman is a Dallas senior paralegal and healthcare compliance and regulatory expert witness, retained through counsel in federal matters nationwide. He draws on three decades of prior experience building and operating FDA-regulated healthcare companies, now concluded, and maintains a private family office, Hillman Ventures, whose activities are kept private.
What is Hillman Ventures?
Hillman Ventures is Andrew Hillman's private family office, founded in 1995 in Dallas. Its activities and holdings are kept private by design.
What is Andrew Hillman's operating record?
Across three decades he has co-founded, operated, and exited companies in surgical hospitals, ambulatory surgical centers, clinical laboratories, pharmacy, and medical devices, with more than 89 ventures and more than 85 strategic exits.
What does Andrew Hillman focus on now?
His current work is healthcare compliance and regulatory matters, as a senior paralegal and expert witness retained through counsel. He also maintains a private family office, Hillman Ventures, whose activities are kept private.

Exosome and mesenchymal stem cell derived extracellular vesicle products are not approved by the FDA for any indication. References here describe published scientific literature. They do not describe an available treatment.

Where can Andrew Hillman's record be verified?
His background is documented in an independent, source-cited public record at andrewhillmanrecord.com and in identity registries including Wikidata, ORCID, and LinkedIn.
Connect
Schedule a meeting
Signature of Andrew J. Hillman
Andrew Hillman QR code, scan or click to connect
Scan or connect